RASSF1A Suppresses Proliferation of Cervical Cancer Cells |
Feng, Lei
(Department of Gynecology and Obstetrics, People's Hospital of Pingyi County)
Li, Jie (Department of Thoracic Surgery, Chinese PLA General Hospital) Yan, Ling-Di (Beijing Institute of Pharmacology and Toxicology) Tang, Jian (Department of Cardio-thoracic Surgery, First Affiliated Hospital of Chinese PLA General Hospital) |
1 | Srivastava A K, Singh P K, Srivastava K, et al (2013). Diagnostic role of survivin in urinary bladder cancer. Asian Pac J Cancer Prev, 14, 81-5. 과학기술학회마을 DOI ScienceOn |
2 | van der Weyden L, Tachibana K K, Gonzalez M A, et al (2005). The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol, 25, 8356-67. DOI |
3 | Vos M D, Dallol A, Eckfeld K, et al (2006). The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem, 281, 4557-63. DOI |
4 | Walboomers J M, Jacobs M V, Manos M M, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. DOI |
5 | Abiramasundari G, Sumalatha K R, Sreepriya M (2012). Effects of Tinospora cordifolia (Menispermaceae) on the proliferation, osteogenic differentiation and mineralization of osteoblast model systems in vitro. J Ethnopharmacol, 141, 474-80. |
6 | Baksh S, Tommasi S, Fenton S, et al (2005). The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell, 18, 637-50. DOI |
7 | Agathanggelou A, Bieche I, Ahmed-Choudhury J, et al (2003). Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res, 63, 5344-51. |
8 | Agathanggelou A, Cooper W N , Latif F (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res, 65, 3497-508. DOI ScienceOn |
9 | Ahmed-Choudhury J, Agathanggelou A, Fenton S L, et al (2005). Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res, 65, 2690-7. DOI |
10 | Blum R, Jacob-Hirsch J, Amariglio N, et al (2005). Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor- 1alpha, causing glycolysis shutdown and cell death. Cancer Res, 65, 999-1006. |
11 | Bos J L (1989). ras oncogenes in human cancer: a review. Cancer Res, 49, 4682-9. |
12 | Dallol A, Agathanggelou A, Fenton S L, et al (2004). RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res, 64, 4112-6. DOI |
13 | Dallol A, Agathanggelou A, Tommasi S, et al (2005). Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res, 65, 7653-9. |
14 | Dammann R, Li C, Yoon J H, et al (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 25, 315-9. DOI ScienceOn |
15 | Jadon R, Pembroke C A, Hanna C L, et al (2014). A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol), 26, 185-96. DOI |
16 | Downward J (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer, 3, 11-22. DOI ScienceOn |
17 | Gao B N, Xie X J, Huang C X, et al (2008). RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res, 68, 22-5. DOI ScienceOn |
18 | Goodsell D S (1999). The molecular perspective: the ras oncogene. Stem Cells, 17, 235-6. DOI |
19 | Liu W J, Tan X H, Guo B P, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a metaanalysis of published data. Asian Pac J Cancer Prev, 14, 3719-24. DOI ScienceOn |
20 | Malumbres M , Barbacid M (2003). RAS oncogenes: the first 30 years. Nat Rev Cancer, 3, 459-65. DOI |
21 | Parkin D M, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
22 | Rahbari R, Sheahan T, Modes V, et al (2009). A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques, 46, 277-84. |
23 | Richter A M, Pfeifer G P , Dammann R H (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta, 1796, 114-28. |
24 | Sherwood V, Recino A, Jeffries A, et al (2010). The N-terminal RASSF family: a new group of Ras-association-domaincontaining proteins, with emerging links to cancer formation. Biochem J, 425, 303-11. DOI |
25 | Matallanas D, Romano D, Yee K, et al (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell, 27, 962-75. DOI |